Innate Pharma SA (IPHA) announced that the FDA has granted Breakthrough Therapy Designation to lacutamab for treating adults ...

The trial will explore the effects of higher doses of ACD856, building on the drug’s established safety profile.

TuHURA Biosciences, a biotech firm, is advancing DNA-based immunotherapy for cancer. Read what warrants a Hold rating for ...

(the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today the approval of an Investigational Review Board (IRB) sanctioned Phase II ...

(MENAFN- Adfactors PR) Bengaluru, January 31, 2025: Cricket legend M.S. Dhoni and Emcure Pharma’s Whole-Time Director Namita Thapar have come together in a powerful conversation to highlight the ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

HOOKIPA Pharma Inc. has announced the completion of participant enrollment in a Phase 1b clinical trial for HB-500, a next-generation therapeutic vaccine aimed at treating HIV. The trial ...

"Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III clinical trial of sparsentan for the treatment of IgA nephropathy in Japan. In April ...

aTyr Pharma ... 2 to resolve inflammation without immune suppression and potentially prevent the progression of fibrosis. aTyr is currently investigating efzofitimod in the global Phase 3 EFZO ...

The shares of this recently listed pharma company rose nearly 2.5 percent after reporting an increase of 27 percent in net profits quarter-over-quarter.Share Price Variation In ...

January 28, 2025 I Herantis Pharma Plc (“Herantis”), a company developing disease-modifying therapies for Parkinson’s disease, is pleased to announce an update of the ongoing Phase 1b clinical trial ...